MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2023 International Congress

    Diabetes impact on nigrostriatal vulnerability in Parkinson’s Disease

    A. Galli, A. Pilotto, C. Zatti, C. Tirloni, A. Lupini, B. Paghera, A. Padovani (Brescia, Italy)

    Objective: aim of the study was to investigate whether diabetes mellitus influences nigrostriatal dopaminergic vulnerability in drug-naïve patients with early-stage Parkinson’s Disease (PD). Background: recently,…
  • 2023 International Congress

    Differential effect of dopaminergic medication on smooth pursuit vs. saccadic eye movements Parkinson’s disease

    M. Mlinarič, A. de Gobiss, V. Groznik, A. Sadikov, D. Georgiev (Ljubljana, Slovenia)

    Objective: To assess the effect of dopaminergic medication on eye movements in Parkinson’s disease (PD). Background: PD is the second most common neurodegenerative disease, characterised…
  • 2023 International Congress

    In silico electrophysiology study reveals the modulating role of calcium channel on Subthalamic nucleus neuronal cells towards Parkinson’s disease

    G. Kuanar, C. Mahapatra (Cuttack, India)

    Objective: The pathogenesis of Parkinson's Disease (PD) is associated with electrical firing patterns of the subthalamic nucleus (STN) neuronal cells. As the dysfunction of the…
  • 2022 International Congress

    Impact of dopamine replacement therapies on MDS-UPDRS II

    F. Nassan, J. Shirvan, M. Yang, T. Dam, J. Wang, N. Maserejian, W. Flanders (Brookline, USA)

    Objective: To estimate the longitudinal effect of different dopamine therapies on the Movement Disorder Society-Sponsored Unified Parkinson's Disease Rating Scale Part II (MDS-UPDRS II) among…
  • 2022 International Congress

    Dopaminergic Denervation as Predictors of Axial Dysfunction in Parkinson’s Disease

    J. Li, N. Phielipp (Irvine, USA)

    Objective: We aimed to assess the usefulness of dopamine binding scores as predictors of walking and balance problems and freezing of gait (FoG) in PD.…
  • 2022 International Congress

    EFFECTS OF DOPAMINERGIC MEDICATION ON REACTIVE AND PROACTIVE INHIBITORY CONTROL

    G. Mirabella, C. Mancini, O. Olivola, A. Rizzardi, V. Di Caprio, E. Ferrari, N. Modugno, A. Pilotto, A. Padovani (Brescia, Italy)

    Objective: In this study, we aim to address the effects of dopaminergic treatment (DT) on the two domains of motor inhibition [1], i.e., reactive (the…
  • 2022 International Congress

    Remission of Gilles de la Tourette Syndrome Following Dehydration

    A. Durbin, M. Rodgers, J. Brasic, D. Wong (Baltimore, USA)

    Objective: To assess the beneficial and adverse effects of heat on a man with Gilles de la Tourette Syndrome (TS) Background: The effect of heat…
  • 2022 International Congress

    Dopaminergic Denervation as Predictors of Falls in PD Patients

    J. Li, N. Phielipp (Irvine, USA)

    Objective: We aimed to predict fall risk in PD patients using SBR data obtained from PPMI. Background: While dopamine is currently considered to be the…
  • 2022 International Congress

    Continuous circadian intracerebroventricular administration of anaerobically preserved dopamine greatly reduces severe L-dopa-related complications in Parkinson’s disease

    C. Moreau, P. Odou, A. Demailly, G. Touzet, N. Reyns, N. Carta, C. Barthelemy, D. Lannoy, B. Palas, B. Gouges, JC. Devedjian, L. Defebvre, M. Fisichella, D. Devos (Lille, France)

    Objective: We aim to demonstrate the safety and efficacy of continuous circadian intracerebroventricular (i.c.v.) administration of anaerobic-dopamine (A-dopamine) to reduce the L-dopa-related complications (LDRC) in…
  • 2022 International Congress

    The agreement between automated and expert FOG annotations during an at-home protocol: influence of dopaminergic medication and task

    N. D'Cruz, D. Zoetewei, T. Herman, P. Ginis, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)

    Objective: To investigate agreement between a recent automated FOG detection algorithm and expert video ratings, and the influence of dopaminergic medication and task context. Background:…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley